Effects in rats of maternal exposure to raspberry leaf and its constituents on the activity of cytochrome p450 enzymes in the offspring

International Journal of Toxicology

Volumn 30, Issue 2, 2011, Pages 216-224

  Makaji, Emilija ^a   Ho, Shirley H Y ^a   Holloway, Alison C ^a   Crankshaw, Denis J ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

cytochrome P450; fluorogenic substrates; imprinting; rat; red raspberry leaf

Indexed keywords

CYTOCHROME P450; KAEMPFEROL; QUERCETIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BIOTRANSFORMATION; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; LIVER MICROSOME; MALE; NONHUMAN; PERINATAL PERIOD; PROGENY; RASPBERRY; RAT;

AGE FACTORS; ANIMALS; BIOTRANSFORMATION; CYTOCHROME P-450 ENZYME SYSTEM; ELLAGIC ACID; FEMALE; KAEMPFEROLS; LIVER; MALE; MATERNAL EXPOSURE; PLANT LEAVES; QUERCETIN; RATS; RATS, WISTAR; ROSACEAE; SEX FACTORS;

ANIMALIA; RATTUS; RUBUS GLAUCUS; RUBUS IDAEUS;

EID: 79955588684     PISSN: 10915818     EISSN: 1092874X     Source Type: Journal    
DOI: 10.1177/1091581810388307     Document Type: Article

References (44)

1. Agrawal AK, Shapiro BH. Neonatal phenobarbital imprints overexpression of cytochromes P450 with associated increase in tumorigenesis and reduced life span. FASEB J. 2005 ; 19 (3). 470-472 (Pubitemid 40316553)
2. Ishizuka M, Yonemoto J, Zaha H, Tohyama C, Sone H. Perinatal exposure to low doses of 2,3,7,8-tetrachlorodibenzo-p-dioxin alters sex-dependent expression of hepatic CYP2C11. J Biochem Mol Toxicol. 2003 ; 17 (5). 278-285 (Pubitemid 37361824)
3. Haake JM, Safe SH. Neonatal phenobarbital imprinting of rat hepatic microsomal testosterone hydroxylations. J Biochem Toxicol. 1988 ; 3: 309-319
4. Raucy JL. Regulation of CYP3A4 expression in human hepatocytes by pharmaceuticals and natural products. Drug Metab Dispos. 2003 ; 31 (5). 533-539 (Pubitemid 36444161)
5. Conover EA. Herbal agents and over-the-counter medications in pregnancy. Best Pract Res Clin Endocrinol Metab. 2003 ; 17 (2). 237-251
6. Nordeng H, Havnen GC. Impact of socio-demographic factors, knowledge and attitude on the use of herbal drugs in pregnancy. Acta Obstet Gynecol Scand. 2005 ; 84 (1). 26-33 (Pubitemid 40179484)
7. Refuerzo JS, Blackwell SC, Sokol RJ, et al. Use of over-the-counter medications and herbal remedies in pregnancy. Am J Perinatol. 2005 ; 22 (6). 321-324 (Pubitemid 41266014)
8. Tsui B, Dennehy CE, Tsourounis C. A survey of dietary supplement use during pregnancy at an academic medical center. Am J Obstet Gynecol. 2001 ; 185 (2). 433-437 (Pubitemid 32769447)
9. Born D, Barron ML. Herb use in pregnancy: what nurses should know. MCN Am J Matern Child Nurs. 2005 ; 30 (3). 201-206
10. Forster DA, Denning A, Wills G, Bolger M, McCarthy E. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy Childbirth. 2006 ; 6: 21
11. Simpson M, Parsons M, Greenwood J, Wade K. Raspberry leaf in pregnancy: its safety and efficacy in labor. J Midwifery Womens Health. 2001 ; 46 (2). 51-59 (Pubitemid 33383952)
12. Gudej J, Tomczyk M. Determination of flavonoids, tannins and ellagic acid in leaves from Rubus L. species. Arch Pharm Res. 2004 ; 27 (11). 1114-1119
13. Obach RS. Inhibition of human cytochrome P450 enzymes by constituents of St. John's Wort, an herbal preparation used in the treatment of depression. J Pharmacol Exp Ther. 2000 ; 294 (1). 88-95 (Pubitemid 30434674)
14. Zhang Z, Hamilton SM, Stewart C, Strother A, Teel RW. Inhibition of liver microsomal cytochrome P450 activity and metabolism of the tobacco-specific nitrosamine NNK by capsaicin and ellagic acid. Anticancer Res. 1993 ; 13 (6A). 2341-2346 (Pubitemid 24036373)
15. Johnson JR, Makaji E, Ho S, Xiong Boya, Crankshaw DJ, Holloway AC. Effect of maternal raspberry leaf consumption in rats on pregnancy outcome and the fertility of the female offspring. Reprod Sci. 2009 ; 16 (6). 605-609
16. Anger DL, Petre M-A, Crankshaw DJ. Heteroactivation of cytochrome P450 1A1 by teas and tea polyphenols. Br J Pharmacol. 2005 ; 145: 926-933 (Pubitemid 41129014)
17. Makaji E, Trambitas CS, Shen P, Holloway AC, Crankshaw DJ. Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms. Toxicol Sci. 2010 ; 113 (2). 293-304
18. Borlakoglu JT, Scott A, Henderson CJ, Wolf CR. Expression of P450 isoenzymes during rat liver organogenesis. Int J Biochem. 1993 ; 25 (11). 1659-1668 (Pubitemid 23323097)
19. de Zwart L, Scholten M, Monbaliu JG, et al. The ontogeny of drug metabolizing enzymes and transporters in the rat. Reprod Toxicol. 2008 ; 26 (3-4). 220-230
20. Kato R, Takanaka A. Metabolism of drugs in old rats. II. Metabolism in vivo and effect of drugs in old rats. Jpn J Pharmacol. 1968 ; 18 (4). 389-396
21. Stresser DM, Turner SD, Blanchard AP, Miller VP, Crespi CL. Cytochrome P450 fluorometric substrates: identification of isoform-selective probes for rat CYP2D2 and human CYP3A4. Drug Metab Dispos. 2002 ; 30 (7). 845-852 (Pubitemid 34671098)
22. Burke MD, Thompson S, Weaver RJ, Wolf CR, Mayer RT. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol. 1994 ; 48 (5). 923-936 (Pubitemid 24285170)
23. Rich KJ, Boobis AR. Expression and inducibility of P450 enzymes during liver ontogeny. Microsc Res Tech. 1997 ; 39 (5). 424-435 (Pubitemid 27523011)
24. Feuer G, Liscio A. Origin of delayed development of drug metabolism in the newborn rat. Nature. 1969 ; 223 (5201). 68-70
25. Schubert I, Netter KJ. Evidence for endogenous triggering of perinatal inducibility of hepatic monooxygenase. Biochem Pharmacol. 1981 ; 30 (21). 2901-2906 (Pubitemid 11031426)
26. Shapiro BH, Agrawal AK, Pampori NA. Gender differences in drug metabolism regulated by growth hormone. Int J Biochem Cell Biol. 1995 ; 27 (1). 9-20
27. Waxman DJ, LeBlanc GA, Morrissey JJ, Staunton J, Lapenson DP. Adult male-specific and neonatally programmed rat hepatic P-450 forms RLM2 and 2a are not dependent on pulsatile plasma growth hormone for expression. J Biol Chem. 1988 ; 263 (23). 11396-11406
28. Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol. 2009 ; 76 (2). 215-228
29. Waxman DJ. Interactions of hepatic cytochromes P-450 with steroid hormones. Regioselectivity and stereospecificity of steroid metabolism and hormonal regulation of rat P-450 enzyme expression. Biochem Pharmacol. 1988 ; 37 (1). 71-84 (Pubitemid 18016749)
30. Legraverend C, Mode A, Westin S, et al. Transcriptional regulation of rat P-450 2C gene subfamily members by the sexually dimorphic pattern of growth hormone secretion. Mol Endocrinol. 1992 ; 6 (2). 259-266
31. Mably TA, Moore RW, Peterson RE. In utero and lactational exposure of male rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin. 1. Effects on androgenic status. Toxicol Appl Pharmacol. 1992 ; 114 (1). 97-107
32. Haake-McMillan JM, Safe SH. Neonatal exposure to Aroclor 1254: effects on adult hepatic testosterone hydroxylase activities. Xenobiotica. 1991 ; 21 (4). 481-489
33. Yao R, Yasuoka A, Kamei A, et al. Dietary flavonoids activate the constitutive androstane receptor (CAR). J Agric Food Chem. 2010 ; 58 (4). 2168-2173
34. Zhang S, Qin C, Safe SH. Flavonoids as aryl hydrocarbon receptor agonists/antagonists: effects of structure and cell context. Environ Health Perspect. 2003 ; 111 (16). 1877-1882 (Pubitemid 37541197)
35. Satsu H, Hiura Y, Mochizuki K, Hamada M, Shimizu M. Activation of pregnane X receptor and induction of MDR1 by dietary phytochemicals. J Agric Food Chem. 2008 ; 56 (13). 5366-5373 (Pubitemid 352039148)
36. Dong H, Lin W, Wu J, Chen T. Flavonoids activate pregnane X receptor-mediated CYP3A4 gene expression by inhibiting cyclin-dependent kinases in HepG2 liver carcinoma cells. BMC Biochem. 2010 ; 11 (1). 23
37. Shen P, Liu MH, Ng TY, Chan YH, Yong EL. Differential effects of isoflavones, from Astragalus membranaceus and Pueraria thomsonii, on the activation of PPARa, PPARg, and adipocyte differentiation in vitro. J Nutr. 2006 ; 136 (4). 899-905
38. Saito K, Kobayashi K, Mizuno Y, Fukuchi Y, Furihata T, Chiba K. Peroxisome proliferator-activated receptor alpha (PPARalpha) agonists induce constitutive androstane receptor (CAR) and cytochrome P450 2B in rat primary hepatocytes. Drug Metab Pharmacokinet. 2010 ; 25 (1). 108-111
39. Badawi AF, Cavalieri EL, Rogan EG. Role of human cytochrome P450 1A1, 1A2, 1B1, and 3A4 in the 2-, 4-, and 16alpha-hydroxylation of 17beta-estradiol. Metabolism. 2001 ; 50 (9). 1001-1003 (Pubitemid 32904154)
40. Pegolo S, Giantin M, Dacasto M, Montesissa C, Capolongo F. Testosterone hydroxylation in bovine liver: enzyme kinetic and inhibition study. Xenobiotica. 2010 ; 40 (4). 255-261
41. http://www.pa2online.org/abstracts/Vol6Issue4abst115P.pdf.
42. Szaefer H, Jodynis-Liebert J, Cichocki M, Matuszewska A, Baer-Dubowska W. Effect of naturally occurring plant phenolics on the induction of drug metabolizing enzymes by o-toluidine. Toxicology. 2003 ; 186 (1-2). 67-77 (Pubitemid 36246620)
43. Barch DH, Rundhaugen LM, Thomas PE, Kardos P, Pillay NS. Dietary ellagic acid inhibits the enzymatic activity of CYP1A1 without altering hepatic concentrations of CYP1A1 or CYP1A1 mRNA. Biochem Biophys Res Commun. 1994 ; 201 (3). 1477-1482 (Pubitemid 24234255)
44. Ahn D, Putt D, Kresty L, Stoner GD, Fromm D, Hollenberg PF. The effects of dietary ellagic acid on rat hepatic and esophageal mucosal cytochromes P450 and phase II enzymes. Carcinogenesis. 1996 ; 17 (4). 821-828 (Pubitemid 26129699)